Publications
Research Articles
1. Hegde, M.; Daimary, U.D.; Kumar, A.; Chinnathambi, A.; Alharbi, S.A.; Shakibaei, M.; Kunnumakkara, A. B. STAT3/HIF1A and EMT specific transcription factors regulated genes: Novel predictors of breast cancer metastasis. Gene. 2022, https://doi.org/10.1016/j.gene.2022.146245, I.F- 3.68
2. Kumar, A.; Singam, A.; Swaminathan, G.; Killi, N.; Tangudu, N. K.; Jose, J.; Gundloori, R.; Kumar, L.D. Combinatorial therapy using RNAi and curcumin nano-architectures regress tumors in breast and colon cancer models. Nanoscale. 2021, https://doi.org/10.1039/D1NR04411G, I.F- 7.79
3. Kourani, K.; Jain, P.; Kumar, A.; Jangid, A. K.; Swaminathan, G.; Reddy, V.D.; Jose, J.; Reddy, R.; Pooja, D.; Kulhari, H.; Kumar, L.D. Inulin Coated Mn3O4 Nanocuboids Coupled with RNA Interference Reverse Intestinal Tumorigenesis in Apc Knockout Murine Colon Cancer Models. Nanomedicine: Nanotechnology, Biology, and Medicine. 2021, https://doi.org/10.1016/j.nano.2021.102504, I.F-6.45, Equal Contribution
4. Buhrmann, C.; Kunnumakkara, A. B.; Kumar, A.; Samec, M.; Kubatka, P.; Aggarwal, B. B.; Shakibaei, M. Multitargeting Effects of Calebin A on Malignancy of CRC Cells in Multicellular Tumor Microenvironment. Frontiers in Oncology. 2021, p 3911. https://doi.org/ 10.3389/fonc.2021.650603. I.F-6.32
5. Kumar, A.; Nayakanti, D. S.; Mangalaparthi, K. K.; Gopinath, V.; Reddy, N. V. N.; Govindan, K.; Voolapalli, G.; Kumar, P.; Kumar, L. D. Quantitative Proteome Profiling Stratifies Fibroepithelial Lesions of the Breast. Oncotarget 2021, 12 (5), 507–518. https://doi.org/10.18632/oncotarget.27889. I.F-3.87
6. Katoch, A.; Nayak, D.; Faheem, M. M.; Kumar, A.; Sahu, P. K.; Gupta, A. P.; Kumar, L. D.; Goswami, A. Natural Podophyllotoxin Analog 4DPG Attenuates EMT and Colorectal Cancer Progression via Activation of Checkpoint Kinase 2. Cell death Discovery. 2021, 7 (1), 25. https://doi.org/10.1038/s41420-021-00405-3. I.F-5.21
7. Chakraborty, S.; Kumar, A; Faheem, M. M.; Katoch, A.; Kumar, A.; Jamwal, V. L.; Nayak, D.; Golani, A.; Rasool, R. U.; Ahmad, S. M.; Jose, J.; Kumar, R.; Gandhi, S. G.; Dinesh Kumar, L.; Goswami, A. Vimentin Activation in Early Apoptotic Cancer Cells Errands Survival Pathways during DNA Damage Inducer CPT Treatment in Colon Carcinoma Model. Cell Death Disease. 2019, 10 (6). https://doi.org/10.1038/s41419-019-1690-2. I.F-8.46
8. Kumar, A.; Nag, R.; Mishra, S.; Ramakrishna, B.; Sai, V. V. R.; Mishra, D. Probable Role of Non-Exosomal Extracellular Vesicles in Colorectal Cancer Metastasis to Kidney: An In Vitro Cell Line Based Study and Image Analysis BT - ICTMI 2017. In Springer Nature; Gulyás, B., Padmanabhan, P., Fred, A. L., Kumar, T. R. S., Kumar, S., Eds.; Springer Singapore Singapore, 2019; pp 163–174
Review Articles
1. Gautam, M.; Kumar, A.; Kuppanur, I.G.; Swaminathan,G.; Dinesh, L.D. Shifting tides from non-targeted chemo drugs to targeted bio drugs - changing dynamics in cancer therapy, Molecular Pharmaceutics, 2023 (In press)
2. Hegde, M.; Kumar, A., Girisa, S.; Aswani, B.S.; Vishwa, R.; Sethi, G.; Kunnumakkara, A.B. Nanoformulations of curcumin: An alliance for effective cancer therapeutics, Food Biosciences, I.F-4.67, 2023, https://doi.org/10.1016/j.fbio.2023.103095
3. Hegde, M.; Kumar, A., Girisa, S.; Alqahtani, S.; Abbas. M.; Goel, A.; Hui, K.M.; Sethi, G.; Kunnumakkara, A.B. Exosomal noncoding RNA-mediated spatiotemporal regulation of lipid metabolism: Implications in immune evasion and chronic inflammation, Cytokine & Growth Factor Reviews, I.F-13.0, 2023, https://doi.org/10.1016/j.cytogfr.2023.06.001
4. Kumar, A., Girisa, S.; Alqahtani, S.; Abbas. M.; Hegde, M.; Sethi, G.; Kunnumakkara, A.B. Targeting Autophagy Using Long Non-Coding RNAs (LncRNAs): New Landscapes in the Arena of Cancer Therapeutics. Cells, I.F-6.0, 2023. https://doi.org/10.3390/cells12050810
5. Girisa, S.; Kumar, A., Kunnumakkara, A.B. Curcumin as a Chemopreventive Agent for Oral Submucous Fibrosis. Oral Submucous Fibrosis: A Guide to Diagnosis and Management, 2023. https://link.springer.com/chapter/10.1007/978-3-031-12855-4_17
6. Kunnumakkara, A.B.; Hegde, M.; Parama, D.; Girisa, S.; Kumar, A., Daimary, U. D.; Garodia, P.; Yenisetti, S.C.; Oommen, O.V.; Aggarwal, B.B. Role of Turmeric and Curcumin in Prevention and Treatment of Chronic Diseases: Lessons Learned from Clinical Trials. ACS Pharmacology and Translational Science, I.F-2.87, 2023. https://doi.org/10.1021/acsptsci.2c00012
7. Kumar, A., Daimary, U. D., Parama, D., & Kunnumakkara, A.B. Curcumin, the golden nutraceutical on the road to cancer therapeutics-a clinical perspective. Critical reviews in Oncogenesis, I.F- 2.89, 2023. doi: 10.1615/CritRevOncog.2023045587
8. Venkat, R.; Verma, E.; Daimary, U. D.; Kumar, A., Girisa, S.; Dutta, U.; Ahn, K.H.; Kunnumakkara, A.B. The journey of resveratrol from vineyards to clinics. Cancer Investigation. 2022. https://doi.org/10.1080/07357907.2022.2115057 I.F-2.38
9. Khatoon, E.; Hegde, M.; Kumar, A., Daimary, U. D.; Sethi, G.; Bishyaee, A.; Kunnumakkara, A.B. The multifaceted role of STAT3 pathway and its implication as a potential therapeutic target in oral cancer. Archives of Pharmacal Research. 2022. https://doi.org/10.1007/s12272-022-01398-y I.F-6.01
10. Sajeev, A.; Hegde, M.; Daimary, U. D.; Kumar, A., Girisa, S.; Sethi, G.; Kunnumakkara, A.B. Modulation of diverse oncogenic signaling pathways by oroxylin A: An important strategy for both cancer prevention and treatment. Phytomedicine. 2022. https://doi.org/10.1016/j.phymed.2022.154369 I.F- 6.67
11. Khatoon, E.; Parama, D.; Kumar, A.; Alqahtani, S.; Abbas. M.; Girisa, S.; Sethi, G.; Kunnumakkara, A.B. Targeting PD-1/PD-L1 axis as new horizon for ovarian cancer therapy. Life Sciences. 2022. https://doi.org/10.1016/j.lfs.2022.120827 I.F-6.78
12. Gangwar, S.K.; Kumar, A.; Chung-Hong, Y.; Jose, S.; Parama, D.; Alqahtani, S.; Abbas. M.; Sethi, G.; Kumar, A.P.; Kunnumakkara, A. B. Targeting Nuclear Receptors in Lung Cancer—Novel Therapeutic Prospects. Pharmaceuticals. 2022. https://doi.org/10.3390/ph15050624 I.F-5.215
13. Hegde, M.; Daimary, U. D.; Girisa, S. Kumar, A.; Kunnumakkara, A. B. Tumor cell anabolism and host tissue catabolism-energetic inefficiency during cancer cachexia. Experimental Biology and Medicine. 2022. https://doi.org/10.1177/15353702221087962 I. F- 3.23
14. Parama, D.; Girisa, S.; Khatoon, E.; Kumar, A.; Alqahtani, M.S.; Abbas, M.; Sethi, G.; Kunnumakkara, A.B. An overview of the pharmacological activities of scopoletin against different chronic diseases. Pharmacological Research. 2022. https://doi.org/10.1016/j.phrs.2022.106202. I.F- 10.33
15. Gangwar, S.K.; Kumar, A.; Jose, S.; Alqahtani, S.; Abbas. M.; Sethi, G.; Kunnumakkara, A. B. Nuclear Receptors in oral cancer- emerging players in tumorigenesis. Cancer Letters, 2022. https://doi.org/10.1016/j.canlet.2022.215666 I.F- 9.765, Equal contribution
16. Naliyadhara, N.; Kumar, A.; Girisa, S.; Daimary, U. D.; Hegde, M.; Kunnumakkara, A. B. Pulsed Electric Field (PEF): Avant-garde Extraction Escalation Technology in Food Industry. Trends in Food Science and Technology, 2022., https://doi.org/10.1016/j.tifs.2022.02.019 I.F- 16.02, Equal Contribution
17. Daimary, U. D.; Girisa, S.; Parama, D.; Verma, E.; Kumar, A.; Kunnumakkara, A. B. Embelin: A Novel XIAP Inhibitor for the Prevention and Treatment of Chronic Diseases. Journal of Biochemical and Molecular Toxicology, 2022. I.F- 3.62
18. Kumar, A.; Harsha, C.; Parama, D.; Girisa, S.; Daimary, U. D.; Mao, X.; Kunnumakkara, A. B. Current Clinical Developments in Curcumin-Based Therapeutics for Cancer and Chronic Diseases. Phytotherapy. Research. 2021. https://doi.org/10.1002/ptr.7264. I.F-5.87
19. Verma, E.; Kumar, A.; Devi Daimary, U.; Parama, D.; Girisa, S.; Sethi, G.; Kunnumakkara, A. B. Potential of Baicalein in the Prevention and Treatment of Cancer: A Scientometric Analyses Based Review. Journal of Functional Foods 2021, 86, 104660. https://doi.org/10.1016/j.jff.2021.104660. I.F-4.45
20. Parama, D.; Rana, V.; Girisa, S.; Verma, E.; Daimary, U. D.; Thakur, K. K.; Kumar, A.; Kunnumakkara, A. B. The Promising Potential of Piperlongumine as an Emerging Therapeutics for Cancer. Exploration of Targeted Anti-tumor Therapy 2021, 2, 323–354. https://doi.org/10.37349/etat.2021.00049.
21. Thakur, K. K.; Kumar, A.; Banik, K.; Verma, E.; Khatoon, E.; Harsha, C.; Sethi, G.; Gupta, S. C.; Kunnumakkara, A. B. Long Noncoding RNAs in Triple-Negative Breast Cancer: A New Frontier in the Regulation of Tumorigenesis. Journal of Cellular Physiology 2021. https://doi.org/10.1002/jcp.30463. I.F-6.38 Equal contribution
22. Swaminathan, G.; Shigna, A.; Kumar, A.; Byroju, V. V.; Durgempudi, V. R.; Dinesh Kumar, L. RNA Interference and Nanotechnology: A Promising Alliance for Next Generation Cancer Therapeutics. Frontiers in Nanotechnology. 2021, p 42. https://doi.org/10.3389/fnano.2021.694838
23. Girisa, S.; Kumar, A.; Rana, V.; Parama, D.; Daimary, U. D.; Warnakulasuriya, S.; Kumar, A. P.; Kunnumakkara, A. B. From Simple Mouth Cavities to Complex Oral Mucosal Disorders- Curcuminoids as a Promising Therapeutic Approach. ACS Pharmacology and Translational Science. 2021, 4 (2), 647–665. https://doi.org/10.1021/acsptsci.1c00017. Equal contribution
24. Rishabh, K.; Khadilkar, S.; Kumar, A.; Kalra, I.; Kumar, A. P.; Kunnumakkara, A. B. MicroRNAs as Modulators of Oral Tumorigenesis-A Focused Review. International Journal of Molecular Sciences 2021, 22 (5). https://doi.org/10.3390/ijms22052561. I.F-5.92
25. Daimary, U. D.; Parama, D.; Rana, V.; Banik, K.; Kumar, A.; Harsha, C.; Kunnumakkara, A. B. Emerging Roles of Cardamonin, a Multitargeted Nutraceutical in the Prevention and Treatment of Chronic Diseases. Current Research in Pharmacology and Drug Discovery. 2021, 2, 100008. https://doi.org/10.1016/j.crphar.2020.100008.
26. Kumar, A.; Golani, A.; Kumar, L. D. EMT in Breast Cancer Metastasis: An Interplay of MicroRNAs, Signaling Pathways and Circulating Tumor Cells. Frontiers in Bioscience- Landmark 2020, 25 (5). https://doi.org/10.2741/4844. I.F-4.23
27. Kumar, M. D.; Dravid, A.; Kumar, A.; Sen, D. Gene Therapy as a Potential Tool for Treating Neuroblastoma-A Focused Review. Cancer Gene Therapy. 2016, 23 (5). https://doi.org/10.1038/cgt.2016.16 I.F- 5.98
Book Chapters
1. Vikkurthi, R.; Kumar, A.; Daimary, U. D.; Girisa, S.; & Kunnumakkara, A. B. Anti-Inflammatory Properties of Dasamoola Plants. In AB Kunnumakkara, D Anindita and R Vikkurthi (Eds.), Dasamoola: The Ten Roots of Ayurveda. Taylor & Francis Group: CRC Press, (2021). ISBN 978-0-367-22898-9 (In Press).
2. Kumar, A.; Daimary, U. D.; Girisa, S.; & Kunnumakkara, A. B. Other Significant Therapeutic Properties of Dasamoola Plants. In AB Kunnumakkara, D Anindita and R Vikkurthi (Eds.), Dasamoola: The Ten Roots of Ayurveda. Taylor & Francis Group: CRC Press, (2021). ISBN 978-0-367-22898-9 (In Press).
3. Vikkurthi, R.; Daimary, U. D.; Parama, D.; Kumar, A.; Girisa, S.; & Kunnumakkara, A. B. Anti-ulcer properties of Dasamoola plants. In AB Kunnumakkara, D Anindita and R Vikkurthi (Eds.), Dasamoola: The Ten Roots of Ayurveda. Taylor & Francis Group: CRC Press, (2021). ISBN 978-0-367-22898-9 (In Press).
4. Rana, V.; Dey, P.; Kumar, A.; Girisa, S.; Kunnumakkara, A. B. Cardioprotective, Hepato Protective and Neuroprotective Properties of Dasamoola Plants. In AB Kunnumakkara, D Anindita and R Vikkurthi (Eds.), Dasamoola: The Ten Roots of Ayurveda. Taylor & Francis Group: CRC Press, (2021). ISBN 978-0-367-22898-9 (In Press).
5. Dey, P.; Vikkurthi, R.; Hegde, M.; Kumar, A.; Kunnumakkara, A. B. Anti-microbial Properties of Dasamoola Plants. In AB Kunnumakkara, D Anindita and R Vikkurthi (Eds.), Dasamoola: The Ten Roots of Ayurveda. Taylor & Francis Group: CRC Press, (2021). ISBN 978-0-367-22898-9 (In Press).
6. Vikkurthi, R.; Kumar, A.; Daimary, U. D.; Girisa, S.; & Kunnumakkara, A. B. Anti-Oxidative Properties of Dasamoola Plants. In AB Kunnumakkara, D Anindita and R Vikkurthi (Eds.), Dasamoola: The Ten Roots of Ayurveda. Taylor & Francis Group: CRC Press, (2021). ISBN 978-0-367-22898-9 (In Press).
7. Rawoof, A.; Kumar, A.; Tiwari, S.; Kumar, L. D. Bioinformatics of MicroRNA Target Prediction. In Bioinformatics and Human Genomics Research; Taylor & Francis Group: CRC Press (2021). ISBN 9780367437602.
8. Swaminathan, G.; Byroju, V. V.; Kumar, A.; Kourani, K.; Kumar, L. D. Acute Lymphoblastic Leukemia : Promising Technologies for the Management of the Disease. In Advances in Health and Disease; Nova Medicine and Health, Nova Science Publishers, (2021); Vol. 37, pp 1–79